Cardioversión en FA/Flutter: manejo antitrombótico
Calcular
Cerrar
Recomendación terapéutica

VKA: Vitamina K antagonistas
*ACO: Dabigatran, Rivaroxaban, Apixaban

Cardioversión recomendaciones Riesgo tromboembolico
CHA²DS²-VASc Score

R.Pitarch ©© 2014

Adaptado de:
  1. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) 2010:Guidelines for the management of atrial fibrillation
  2. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation